Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Charlie Hospital Semarang Tbk. (RSCH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp310 (market cap 816.2B, 25.44M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 2.6× Diagnos Laboratorium Utama Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (25.44M versus 41.7K). Which is the better fit depends on your goals.
| DGNS | RSCH | |
|---|---|---|
Market Cap | 316.25B | 816.2B |
Volume | 41.7K | 25.44M |
Lot | 417 | 254.36K |
Turnover | 9.66M | 7.84B |
Average Price | 231.65 | 308.07 |
Value | 9.66M | 7.84B |
Indicative Equilibrium Price | 230 | 310 |
Indicative Equilibrium Volume | 2.4K | 100 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Charlie Hospital Semarang Tbk.
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →
